Patients with certain GLP1R variants may achieve stronger appetite suppression at lower doses, while others may benefit from higher titration
Source: University of Colorado A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Like its once-weekly counterpart, the pill is also approved to reduce cardiovascular risk, reinforcing the idea that GLP-1 medications are now viewed as long-term metabolic therapies rather than short-term weight-loss tools
Administration and dosing Semaglutide with B12 is administered the same way as semaglutide injections
Shankar V, Wilhelmy J, Curtis EJ, Michael B, Cervantes L, Mallajosyula V, et al
Our diets are dominated by cheap, over sized, highly processed, addictive, and nutrient-deficient foods, fueling obesity and metabolic disorders